342 related articles for article (PubMed ID: 32474012)
21. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER
Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093
[TBL] [Abstract][Full Text] [Related]
22. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
[TBL] [Abstract][Full Text] [Related]
23. Uterine fibroids: a review of health-related quality of life assessment.
Williams VS; Jones G; Mauskopf J; Spalding J; DuChane J
J Womens Health (Larchmt); 2006 Sep; 15(7):818-29. PubMed ID: 16999637
[TBL] [Abstract][Full Text] [Related]
24. Sexual functioning and psychological well-being after uterine artery embolization in women with symptomatic uterine fibroids.
Voogt MJ; De Vries J; Fonteijn W; Lohle PN; Boekkooi PF
Fertil Steril; 2009 Aug; 92(2):756-61. PubMed ID: 18692808
[TBL] [Abstract][Full Text] [Related]
25. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
26. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
[TBL] [Abstract][Full Text] [Related]
27. Postoperative Quality of Life and Sexual Function in Premenopausal Women Undergoing Laparoscopic Myomectomy for Symptomatic Fibroids: A Prospective Observational Cohort Study.
Radosa JC; Radosa CG; Mavrova R; Wagenpfeil S; Hamza A; Joukhadar R; Baum S; Karsten M; Juhasz-Boess I; Solomayer EF; Radosa MP
PLoS One; 2016; 11(11):e0166659. PubMed ID: 27898669
[TBL] [Abstract][Full Text] [Related]
28. A Systematic Review of the Psychosocial Impact of Endometriosis before and after Treatment.
Rempert AN; Rempert TH; Liu A; Hernández A; Blanck J; Segars J; Singh B
Reprod Sci; 2024 Mar; ():. PubMed ID: 38512699
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.
Lethaby A; Vollenhoven B; Sowter M
BJOG; 2002 Oct; 109(10):1097-108. PubMed ID: 12387461
[TBL] [Abstract][Full Text] [Related]
31. Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids.
Strand T; Kives S; Leyland N; Ashkenas J; Janiszewski P; Thiel J
J Obstet Gynaecol Can; 2020 Dec; 42(12):1475-1482.e2. PubMed ID: 33046429
[TBL] [Abstract][Full Text] [Related]
32. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
Obstet Gynecol; 2021 Jun; 137(6):e100-e115. PubMed ID: 34011888
[TBL] [Abstract][Full Text] [Related]
33. Impact of uterine fibroids on quality of life: a national cross-sectional survey.
Hervé F; Katty A; Isabelle Q; Céline S
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():32-37. PubMed ID: 30099225
[TBL] [Abstract][Full Text] [Related]
34. The Impact of Fertility Goals on Long-term Quality of Life in Reproductive-aged Women Who Underwent Myomectomy versus Hysterectomy for Uterine Fibroids.
Frisch EH; Mitchell J; Yao M; Llarena N; Omosigho UR; DeAngelo L; Arakelian M; Bradley L; Falcone T
J Minim Invasive Gynecol; 2023 Aug; 30(8):642-651. PubMed ID: 37044261
[TBL] [Abstract][Full Text] [Related]
35. Ulipristal acetate on quality of life and sexual function of women with uterine fibromatosis.
Biscione A; Barra V; Bellone E; Severi FM; Luisi S
Gynecol Endocrinol; 2020 Jan; 36(1):87-92. PubMed ID: 31328597
[TBL] [Abstract][Full Text] [Related]
36. Influence of Ethnicity on Clinical Presentation and Quality of Life in Women With Uterine Fibroids: Results From a Prospective Observational Registry.
Murji A; Bedaiwy M; Singh SS; Bougie O;
J Obstet Gynaecol Can; 2020 Jun; 42(6):726-733.e1. PubMed ID: 31882290
[TBL] [Abstract][Full Text] [Related]
37. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL).
Harding G; Coyne KS; Thompson CL; Spies JB
Health Qual Life Outcomes; 2008 Nov; 6():99. PubMed ID: 19014505
[TBL] [Abstract][Full Text] [Related]
38. Non-extirpative Treatments for Uterine Myomas: Measuring Success.
Cope AG; Young RJ; Stewart EA
J Minim Invasive Gynecol; 2021 Mar; 28(3):442-452.e4. PubMed ID: 32841756
[TBL] [Abstract][Full Text] [Related]
39. EMAS position statement: management of uterine fibroids.
Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
[TBL] [Abstract][Full Text] [Related]
40. A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry.
Anchan RM; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL; Spies JB
J Womens Health (Larchmt); 2023 Apr; 32(4):423-433. PubMed ID: 36637808
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
